Introduction Radical cystectomy is the gold standard for treating invasive bladder cancer. We report
our outcomes of gasless minimum incision access (GMIA) for extracorporeal orthotopic bladder substitution
(ECOBS) after...
Introduction Objectives were to evaluate safety and patient reported perception of the Martius fibroadipose
flap for complex female urethra reconstruction.
Material and methods Patients operated with a Martius flap were...
We present our experience with intratesticular hematoma (ITH) without rupture of the tunica albuginea following blunt scrotal trauma and present an algorithm for management. We reviewed the charts of 3 patients who prese...
Introduction We aimed to investigate the effectiveness and safety of flurbiprofen, a non−steroidal anti−in-flammatory drug with dual cyclooxygenase inhibition, and α−blocker alfuzosin, both alone and in combina-tion with...
Gasless minimum incision access used for extracorporeal orthotopic bladder substitution after laparoscopic radical cystectomy
Introduction Radical cystectomy is the gold standard for treating invasive bladder cancer. We report our outcomes of gasless minimum incision access (GMIA) for extracorporeal orthotopic bladder substitution (ECOBS) after...
Use of Martius flap in the complex female urethral surgery
Introduction Objectives were to evaluate safety and patient reported perception of the Martius fibroadipose flap for complex female urethra reconstruction. Material and methods Patients operated with a Martius flap were...
Intratesticular hematoma after blunt scrotal trauma: a case series and algorithm–based approach to management
We present our experience with intratesticular hematoma (ITH) without rupture of the tunica albuginea following blunt scrotal trauma and present an algorithm for management. We reviewed the charts of 3 patients who prese...
Flurbiprofen alone and in combination with alfuzosin for the management of lower urinary tract symptoms
Introduction We aimed to investigate the effectiveness and safety of flurbiprofen, a non−steroidal anti−in-flammatory drug with dual cyclooxygenase inhibition, and α−blocker alfuzosin, both alone and in combina-tion with...
AUTHOR’S REPLY
Author's Reply